Assoc. Prof.  

Dominika Wcislo-Dziadecka

, Poland


Presentations

Changes of body mass index as a result of treatment with adalimumab. 09 October 2019 00:00 - 00:00
Assessment of the systemic effects of the subcutaneous administration of the adalimumab bilogical drug to patients with psoriatic arthritis. 09 October 2019 00:00 - 00:00
The effect of adalimumab on the changes on expression on patterns of genes connecting IL12/23 and angiogenesis in NHDF cell culture and PBM cells. 09 October 2019 00:00 - 00:00
The Micrroarray expression profile of miRNas constituting a link between expression  pathways JAK/STAT with a histaminergic  system. 09 October 2019 00:00 - 00:00
Transciptional activity of BCL2L1gene in patients treated with biological drugs. 09 October 2019 00:00 - 00:00
The molecular and clinical rating of the effectiveness of ustekinumab in patients with psoriasis vulgaris. 09 October 2019 00:00 - 00:00
The opportunity to use the changes in the transcriptional activity of TNFalfa, TNFR1, TNFR2  in the monitoring of the effectiveness  of etanercept therapy  in regard to patients with psoriatis arthritis. 09 October 2019 00:00 - 00:00
Comparing the expression profile of TGFB1-3 and the value of clinical advancement indicators of psoriasis during cyclosporin A therapy dependant on the co-occurence of the metabolic syndrom. 09 October 2019 00:00 - 00:00

Abstracts

Changes of body mass index as a result of treatment with adalimumab. Biologics, Immunotherapy, Molecularly Targeted Therapy More
Assessment of the systemic effects of the subcutaneous administration of the adalimumab bilogical drug to patients with psoriatic arthritis. Biologics, Immunotherapy, Molecularly Targeted Therapy More
Comparing the expression profile of TGFB1-3 and the value of clinical advancement indicators of psoriasis during cyclosporin A therapy dependant on the co-occurence of the metabolic syndrom. Psoriasis More
The effect of adalimumab on the changes on expression on patterns of genes connecting IL12/23 and angiogenesis in NHDF cell culture and PBM cells. Biologics, Immunotherapy, Molecularly Targeted Therapy More
The Micrroarray expression profile of miRNas constituting a link between expression  pathways JAK/STAT with a histaminergic  system. Biologics, Immunotherapy, Molecularly Targeted Therapy More
Transciptional activity of BCL2L1gene in patients treated with biological drugs. Biologics, Immunotherapy, Molecularly Targeted Therapy More
The molecular and clinical rating of the effectiveness of ustekinumab in patients with psoriasis vulgaris. Biologics, Immunotherapy, Molecularly Targeted Therapy More
The opportunity to use the changes in the transcriptional activity of TNFalfa, TNFR1, TNFR2  in the monitoring of the effectiveness  of etanercept therapy  in regard to patients with psoriatis arthritis. Biologics, Immunotherapy, Molecularly Targeted Therapy More